Saudi Arabia Over the Counter (OTC) Drugs Market by Product Type (Cough, Cold and Flu Drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cessation Aids, Ophthalmics, Vitamins and Minerals, Sleep Aids, Weight Loss/Diet Drugs and Others (Ear Drops & Diuretics)), by Formulation Type (Liquids, Ointments, Tablets and Sprays) and by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets and Convenience stores) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Saudi Arabia Over the Counter (OTC) Drugs Market by Product Type (Cough, Cold and Flu Drugs, Analgesics, Dermatologics, Gastrointestinal Drugs, Antiseptics, Anti-Allergy Drugs, Smoking Cessation Aids, Ophthalmics, Vitamins and Minerals, Sleep Aids, Weight Loss/Diet Drugs and Others (Ear Drops & Diuretics)), by Formulation Type (Liquids, Ointments, Tablets and Sprays) and by Distribution Channel (Pharmacies, Supermarkets/Hypermarkets and Convenience stores) - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 958 | Pages: 121 | October 2016 | Region: Saudi Arabia


The Saudi Arabia OTC Drugs Market has been estimated as 614 million in 2016 with a growing potential of 9.2%. Saudi Arabia OTC Drugs market accounts for XX% of total Middle East and Africa OTC market.

The term ‘’Over the counter’’ mentions to pharmaceuticals, which are bought across the counter without any need of physicians prescription. OTC drugs are used to treat and prevent minor disorders, as growing aging population there is an increasing push to be able to license OTC medicines for the use of treatment of chronic conditions.

Saudi Arabia OTC Drugs market expected to maintain strong growth drive owing to rapidly growing population coupled with strong inflow of emigrants into the country. Saudi Arabia OTC Drugs market is dominated by branded drugs of various international market leaders and these drugs are wholesaled under second brand name in association with local companies and distributors.

The Saudi Arabia OTC Drugs market is driven by factors such as increasing prevalence of seasonal diseases, increasing awareness of self-medication and the proper use of medications and strong brand reliability for multinational drugs in Saudi Arabia are factors expected to drive demand for OTC Drugs market over the forecast period. Moreover, increasing disposable income, healthcare spending, growing healthcare infrastructure and growing assault of health insurance companies in the Saudi Arabia is increasing growth of the OTC Drugs market in Saudi Arabia.  However, deficient in research capabilities and lack of specific product availability in old-fashioned distribution channels and growing competition from other retail channels which leads to an insignificant decline in the overall value share of distribution channels are the major factor inhibiting the growth of the OTC drugs market in Saudi Arabia.

The Saudi Arabia OTC drugs market has been segmented by formulation type - tablets, liquids, ointments, sprays others. By product type – market has been segmented into cough and cold flu drugs, analgesics, dermatologics, gastrointestinal drugs, antiseptics, anti-allergy drugs, smoking cessation aids, vitamins and minerals, ophthalmics, sleep aids, weightloss/diet drugs and others (Ear Drops & Diuretics). By distribution channels market has been segmented into pharmacies/drug stores, supermarkets/hypermarkets, convenience stores, others (online drug stores).

Some of the key players dominating the OTC Drugs market in Saudi Arabia are GlaxoSmithKline Pharmaceuticals Ltd, Gulf Pharmaceutical Industries, Tabuk Pharmaceutical Manufacturing Co, Jamjoom Pharmaceuticals Co. Ltd., and Reckitt Benckiser Group plc.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product Type                             

                                5.1.1 Analgesics

                                5.1.2 Cough, Cold and Flu Products         

                                5.1.3 Vitamins and Minerals       

                                5.1.4 Dermatological Products   

                                5.1.5 Gastrointestinal Products 

                                5.1.6 Ophthalmic Products          

                                5.1.7 Sleep Aid Products              

                                5.1.8 Weight Loss/Diet Products               

                                5.1.9 Others      

                5.2 By Formulation Type                              

                                5.2.1 Tablets      

                                5.2.2 Liquids      

                                5.2.3 Ointments               

                                5.2.4 Sprays       

                5.3 Distribution Channels                             

                                5.3.1 Pharmacies             

                                5.3.2 Supermarkets/Hypermarkets         

                                5.3.3 Convenience stores            

                                5.3.4 Others (Online Drug Stores)            

6. Strategic Analysis                                       

                6.1 PESTLE analysis                         

                                6.1.1 Political     

                                6.1.2 Economic 

                                6.1.3 Social         

                                6.1.4 Technological         

                                6.1.5 Legal          

                                6.1.6 Environmental       

                6.2 Porter’s Five analysis                              

                                6.2.1 Bargaining Power of Suppliers        

                                6.2.2 Bargaining Power of Consumers    

                                6.2.3 Threat of New Entrants     

                                6.2.4 Threat of Substitute Products and Services              

                                6.2.5 Competitive Rivalry within the Industry     

7. Market Leaders' Analysis                                        

                7.1 GlaxoSmithKline                       

                                7.1.1 Overview 

                                7.1.2 Product Analysis   

                                7.1.3 Strategic Evaluation and Operations            

                                7.1.4 Financial analysis  

                                7.1.5 Legal issues             

                                7.1.6 Recent Developments       

                                7.1.7 SWOT analysis       

                                7.1.8 Analyst View          

                7.2 Gulf Pharmaceutical Industries,                         

                7.3 Tabuk Pharmaceutical Manufacturing Co                      

                7.4 Jamjoom Pharmaceuticals Co. Ltd                    

                7.5 Reckitt Benckiser Group plc                 

                7.6 Johnson and Johnson                            

                7.7 Novartis                       

                7.8 Bayer                            

                7.9 Pfizer                            

                7.10 Boehringer Ingelheim                          

                7.11 Sanofi                         

8. Competitive Landscape                                           

                8.1 Market share analysis                            

                8.2 Merger and Acquisition Analysis                       

                8.3 Agreements, collaborations and Joint Ventures                         

                8.4 New Product Launches                         

9. Expert Opinions                                          

                9.1 Market Outlook                        

                9.2 Investment Opportunities                   

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
Middle East And Africa Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & ...
Latin America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Asia Pacific Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnol...
Europe Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Co...
North America Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechno...
Western Blotting Market By Product (Instruments, Consumables), Application (Biomedical & Biochemical Research, Disease Diagnostics), End User (Academic & Research Institutes, Pharmaceutical & Biotechnology Companies...
Middle East And Africa Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics),...
Latin America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Asia Pacific Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User ...
Europe Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospi...
North America Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User...
Multiplex Assays Market By Product (Consumable, Kits & Reagents, Panels), Type (nucleic Acid-Based, Protein-Based), Technology (PCR, Multiplex Array), Application (R&D, Companion Diagnostics), End User (Hospital, Cl...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.